Ardelyx Inc. buy Wolf_of_WS
Summary
This prediction is currently active. The BUY prediction by Wolf_of_WS for Ardelyx Inc. is nearly unchanged. This prediction currently runs until 02.07.25. The prediction end date can be changed by Wolf_of_WS at any time. Wolf_of_WS has 50% into this predictionArdelyx, Inc. is a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medicines aimed at treating kidney and cardiovascular diseases. The company uses a unique approach to drug discovery, developing therapeutics that target ion channels and transporters, which play a critical role in regulating activities in the body. Ardelyx's lead product candidate, tenapanor, is being studied for the treatment of conditions such as hyperphosphatemia in patients with chronic kidney disease, irritable bowel syndrome with constipation, and diverticulosis. The company is listed on the NASDAQ exchange under the ticker symbol ARDX.
Performance without dividends (%)
Name | 1w |
---|---|
Ardelyx Inc. | 0.83% |
iShares Core DAX® | -0.145% |
iShares Nasdaq 100 | 1.296% |
iShares Nikkei 225® | 1.282% |
iShares S&P 500 | 0.442% |
Comments by Wolf_of_WS for this prediction
In the thread Ardelyx Inc. diskutieren